APCDD1 and carcinoma: For example, the progression to adenoma and carcinoma was pronounced at 6.5 months: 5 of 16 hTS/Men1–/– mice developed carcinoma (31.3%) as compared with 0 of 16 Men1–/– mice with carcinoma at this time point (0%).